| Literature DB >> 25177879 |
Zohra S Lassi, Rehana A Salam, Jai K Das, Zulfiqar A Bhutta.
Abstract
Worldwide, 250,000-280,000 women die during pregnancy and childbirth every year and an estimated 6.55 million children die under the age of five. The majority of maternal deaths occur during or immediately after childbirth, while 43% of child death occurs during the first 28 days of life. However, the progress in limiting these has been slow and sporadic. In this supplement of five papers, we aim to systematically assess and summarize essential interventions for reproductive, maternal, newborn and child health from relevant systematic reviews. This paper is an introductory paper detailing the background and methodology used for grading interventions. The following three papers summarize the evidence on essential interventions for pre-pregnancy, pregnancy, childbirth, postnatal (mother and neonatal) and child heath while the last paper describes the essential interventions as per the level of health care delivery and their proposed packages of care.Entities:
Mesh:
Year: 2014 PMID: 25177879 PMCID: PMC4145855 DOI: 10.1186/1742-4755-11-S1-S1
Source DB: PubMed Journal: Reprod Health ISSN: 1742-4755 Impact factor: 3.223
Classification of interventions according to evidence and delivery strategies
| Category | Evidence for intervention GRADE categories | Delivery strategies | Action |
|---|---|---|---|
| Intervention evidence agreed | Delivery strategy agreed | Disseminate for rapid scale up | |
| Intervention evidence agreed | Delivery strategy no consensus | Collate evidence and define gaps in evidence for delivery strategies – seek consensus | |
| Intervention evidence still questioned | Delivery strategy no consensus | Prioritise action and further research required or delete | |
| A | B | C | D | E |
|---|---|---|---|---|
| Interventions that are beneficial | Interventions likely to be beneficial | Interventions with a trade-off between beneficial and adverse effects | Interventions of unknown effect, including absence of reviews | Interventions likely to be ineffective or harmful |
Grading of interventions according to the level of health care delivery
| Intervention | Referral level | 1st level / outreach | Community |
|---|---|---|---|
| Family planning | A | A | A |
| Prevent& manage sexually transmitted illness including HIV for prevention and mother to child transmission for HIV and syphilis | A | A | A |
| Folic acid fortification and/or supplementation for preventing neural tube defects | A | A | A |
| Management of unintended pregnancy | A | B | - |
| A | A | C | |
| Reduce malpresentation at term with external cephalic version | A | - | - |
| Management of pre-eclampsia | A | B | - |
| Magnesium sulphate for eclampsia | A | C | - |
| Induction of labor to manage premature rupture of membranes at term | A | - | - |
| Antibiotics for preterm rupture of membranes | A | B | - |
| Corticosteroids to prevent respiratory distress syndrome in newborns | A | - | - |
| Prophylactic antibiotics for caesarean section | A | - | - |
| Management of postpartum hemorrhage (e.g. uterotonics, uterine massage) | A | B | C |
| Active management of third stage of labor to prevent postpartum hemorrhage | A | A | - |
| Cesarean section for absolute maternal indication | A | - | - |
| Induction of labor for prolonged pregnancy | A | - | - |
| Prophylactic uterotonics to prevent postpartum hemorrhage | A | B | C |
| Family planning | A | A | A |
| Prevent and treat maternal anemia | A | B | - |
| Detect and manage postpartum sepsis | A | B | - |
| Screen and initiate or continue antiretroviral therapy for HIV | A | A | - |
| Immediate thermal care | A | B | B |
| Initiation of exclusive breastfeeding (within first hour) | A | A | A |
| Hygienic cord and skin care | A | B | B |
| Neonatal resuscitation with bag and mask (professional health worker) | A | B | - |
| Case management of neonatal sepsis, meningitis and pneumonia | A | B | - |
| Kangaroo mother care for preterm and for less than 2000g babies | A | B | - |
| Management of newborns with jaundice | A | B | - |
| Surfactant to prevent respiratory distress syndrome in preterm babies | A | - | - |
| Continuous positive airway pressure (CPAP) to manage babieswith respiratory distress syndrome | A | - | - |
| Extra support for feeding small and preterm babies | A | B | - |
| Presumptive antibiotic therapy for newborns at risk of bacterial infections | A | - | - |
| Exclusive breastfeeding for 6 months | A | A | A |
| Continued breastfeeding and complementary feeding from 6 months | A | A | A |
| Prevention and case management of childhood malaria | A | A | A |
| Vitamin A supplementation from 6 months of age | A | A | A |
| Comprehensive care of children infected with or exposed to HIV infection | A | A | - |
| Routine Immunization and H. influenzae, meningococcal, pneumococcal and Rota virus vaccines | A | A | B |
| Management of severe acute malnutrition | A | A | - |
| Case management of childhood pneumonia | A | A | A |
| Case management of diarrhea | A | A | A |
| Home visits for women and children across the continuum of care | - | - | A |